Is Cryoprecipitate-Reduced Plasma an Efficacious Replacement Fluid for Therapeutic Plasma Exchange for Patients with Thrombotic Microangiopathy? A Single-Center Retrospective Experience.

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Laboratoriums Medizin

• Publication date

  2021-11-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/labmed/lmab092PMID 34791373
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

  2019cited by this paper
• Combination of Fresh Frozen Plasma and Cryosupernatant Plasma for Therapeutic Plasma Exchange in Thrombotic Thrombocytopenic Purpura: A Single Institution Experience

  2019cited by this paper
• Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products

  2015cited by this paper
• Safety and efficacy of cryoprecipitate‐poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: A single center retrospective evaluation

  2014cited by this paper
• Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study.

  2007cited by this paper
• Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet

  2005cited by this paper
• Thrombotic microangiopathies.

  2002cited by this paper
• Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP)

  2001cited by this paper
• Design of the prospective randomized study for the treatment of patients with thrombotic microangiopathy. PRODROMI Study Group.

  2000cited by this paper
• Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura

  1996cited by this paper
• Influence of type of exchange fluid on survival in therapeutic apheresis for thrombotic thrombocytopenic purpura

  1995cited by this paper
• Effectiveness of cryosupernatant therapy in refractory and chronic relapsing thrombotic thrombocytopenic purpura

  1993cited by this paper
• Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.

  1991cited by this paper
• Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura

  1990cited by this paper

• Comparing cryoprecipitate-poor plasma to fresh frozen plasma as replacement therapy in thrombotic thrombocytopenic purpura: An updated meta-analysis.

  2024cites this paper